Myomectomy Market Research Report - Global Forecast till 2023

Myomectomy market research report–by type (abdominal, hysteroscopic, laparoscopic, robotic), product (laparoscopic power morcellators, harmonic scalpel, laparoscopic sealers), end user (hospitals, surgical centers, medical device companies) - Global forecast till 2023

ID: MRFR/MED/3713-HCR | | Region: Global | 110 pages

Market Synopsis of the Global Myomectomy Market

Myomectomy a surgical procedure for the removal uterine fibroids. Uterine fibroids are common noncancerous growth in the uterus of women at their child bearing age, causing symptoms such as heavy bleeding during menstrual cycle, increased menstrual cramping, pain in pelvis or lower back, and swelling enlargement of the abdomen. Myomectomy differs from hysterectomy. During myomectomy, the surgeons remove only the fibroids in the uterus while in hysterectomy entire uterus is removed. This procedure preserves the chances of women getting pregnant. There are four types of myomectomy namely; abdominal, hysteroscopic, laparoscopic, and robotic. Results of myomectomy are found to be better and women report improvement in fibroid symptoms, such as heavy menstrual bleeding and pelvic pressure.


Rising prevalence of uterine fibroids, and increasing demand for diagnosis and treatment of uterine disorder. Additionally, increasing demand for medical devices for gynecology procedures also fuel the growth of the market. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Splendid research in the field of reproductive health and diseases also boost the market.


The growth of medical device industry and increasing demand for technological advanced medical devices also fuels the growth of the market across the globe. However, the growth of the market is restricted due to increasing competition among existing players and high cost of medical devices.


According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s. Not all women with fibroids have symptoms; nearly 45% to 50% of the women do not exhibit symptoms in their lifespan. Increase in the age also affect the prevalence rate of uterine fibroids.


The global myomectomy market is expected to grow at a CAGR of 6.9% during the forecast period.


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Healthcare IT Companies

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


FIGURE 1: Global Myomectomy Market by Region, 2016 (%)


Myomectomy Market

Source: World Health Organization, Centers for Disease Control and Prevention, U.S. National Library of Medicine, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Segments 


The global myomectomy market is segmented on the basis of type, product, and end user.


On the basis of type, market is segmented into abdominal, hysteroscopic, laparoscopic, and robotic.


On the basis of product, the market is segmented into laparoscopic power morcellators, harmonic scalpel, laparoscopic sealer, and others.


On the basis of end user, the market is segmented into hospitals & clinics, surgical centers, medical device companies, and others.


Regional Analysis of the Global Myomectomy Market             


America holds the first position in the market for myomectomy owing to the rising prevalence of uterine disorders in the U.S., and increasing demand for new diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare IT industry.  Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.


Europe is the second largest market for myomectomy. In Europe, there is an increasing demand for medical devices and availability of funds for research and development activities in the reproductive health. The growth of surgical devices in Germany, France, and U.K also fuels the growth of the market.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing women suffering from uterine disorders, and rising investment in surgical device industry by key players in developing economies throughout Asia Pacific. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand technologically advanced medical devices such as gene chips for research activities, and availability of highly qualified medical professional such as surgeons and gynecologists.


The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about diagnosis and treatment of uterine fibroids. In the Middle East & Africa, Middle East captures the largest market share for myomectomy owing to the availability of better healthcare infrastructure, availability of specialty services and wide scope for research.
Research Methodology
Myomectomy Market 2018


Key Players in the Global Myomectomy Market           


Some of the key players in this market are Halt Medical, Inc. (U.K), Boston Scientific Corporation (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), General Electric Company (U.S.), KARL STORZ SE & Co. KG (Germany), Richard Wolf Medical Instruments (U.S.), Siemens (U.S.), AbbVie Inc. (U.S.), Bayer (Germany), Eli Lilly and Company (U.S.), Johnson & Johnson Services Inc. (U.S.) and others.







 



Frequently Asked Questions (FAQ) :


Global myomectomy market is expected to expand at 6.9% CAGR from 2017 to 2023.

High prevalence of uterine fibroids and demand for treatment of uterine disorders are primary drivers of the global myomectomy market.

Competition among players and high costs of diagnostic devices are factors expected to hamper the global myomectomy market growth.

The Americas is predicted to dominate in the global myomectomy market till 2023.

Richard Wolf Medical Instruments, F. Hoffmann-La Roche Ltd, KARL STORZ SE & Co. KG, Siemens, Boston Scientific Corporation, General Electric Company, AbbVie Inc., Eli Lilly and Company, Halt Medical, Inc., CooperSurgical Inc., C. R. Bard, Inc., Bayer, and Johnson & Johnson Services Inc. are prominent players of the global myomectomy market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Myomectomy Market, by Type

6.1 Introduction

6.2 Abdominal

6.2.1 Market Estimates & Forecast, 2017-2023

6.3 Laparoscopic

6.3.1 Market Estimates & Forecast, 2017-2023

6.4 Hysteroscopic

6.4.1 Market Estimates & Forecast, 2017-2023

6.5 Robotic

6.5.1 Market Estimates & Forecast, 2017-2023


7. Global Myomectomy Market, by Product

7.1 Introduction

7.2 Laparoscopic power morcellators

7.2.1 Market Estimates & Forecast, 2017-2023

7.3 Harmonic scalpel

7.3.1 Market Estimates & Forecast, 2017-2023

7.4 Laparoscopic Sealer

7.4.1 Market Estimates & Forecast, 2017-2023

7.5 Others

7.5.1 Market Estimates & Forecast, 2017-2023

8. Global Myomectomy Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2017-2023

8.3 Surgical Centers

8.3.1 Market Estimates & Forecast, 2017-2023

8.4 Medical Device Companies

8.4.1 Market Estimates & Forecast, 2017-2023

8.5 Others

8.5.1 Market Estimates & Forecast, 2017-2023

9. Global Myomectomy Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Halt Medical, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Boston Scientific Corporation

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 CooperSurgical Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 F. Hoffmann-La Roche Ltd

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 C. R. Bard, Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Siemens

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Richard Wolf Medical Instruments

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Karl Storz Endoscopy

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Device Industry

13 Appendix


LIST OF TABLES

Table 1 Myomectomy Industry Synopsis, 2017-2023

Table 2 Global Myomectomy Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3 Global Myomectomy Market by Region, 2017-2023, (USD Million)

Table 4 Global Myomectomy Market by Types, 2017-2023, (USD Million)

Table 5 Global Myomectomy Market by Product, 2017-2023, (USD Million)

Table 7 Global Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 8 North America Myomectomy Market by Types, 2017-2023, (USD Million)

Table 9 North America Myomectomy Market by Product, 2017-2023, (USD Million)

Table 11 North America Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 12 US Myomectomy Market by Types, 2017-2023, (USD Million)

Table 13 US Myomectomy Market by Product, 2017-2023, (USD Million)

Table 15 US Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 16 Canada Myomectomy Market by Types, 2017-2023, (USD Million)

Table 17 Canada Myomectomy Market by Product, 2017-2023, (USD Million)

Table 19 Canada Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 20 South America Myomectomy Market by Types, 2017-2023, (USD Million)

Table 21 South America Myomectomy Market by Product, 2017-2023, (USD Million)

Table 23 South America Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 24 Europe Myomectomy Market by Types, 2017-2023, (USD Million)

Table 25 Europe Myomectomy Market by Product, 2017-2023, (USD Million)

Table 27 Europe Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 28 Western Europe Myomectomy Market by Types, 2017-2023, (USD Million)

Table 29 Western Europe Myomectomy Market by Product, 2017-2023, (USD Million)

Table 31 Western Europe Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 32 Eastern Europe Myomectomy Market by Types, 2017-2023, (USD Million)

Table 33 Eastern Europe Myomectomy Market by Product, 2017-2023, (USD Million)

Table 35 Eastern Europe Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 36 Asia Pacific Myomectomy Market by Types, 2017-2023, (USD Million)

Table 37 Asia Pacific Myomectomy Market by Product, 2017-2023, (USD Million)

Table 39 Asia Pacific Myomectomy Market by End Users, 2017-2023, (USD Million)

Table 40 Middle East & Africa Myomectomy Market by Types, 2017-2023, (USD Million)

Table 41 Middle East & Africa Myomectomy Market by Product, 2017-2023, (USD Million)

Table 43 Middle East & Africa Myomectomy Market by End Users, 2017-2023, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Myomectomy Market

Figure 3 Segmentation Market Dynamics for Myomectomy Market

Figure 4 Global Myomectomy Market Share, by Type, 2016

Figure 5 Global Myomectomy Market Share, by Product, 2016

Figure 6 Global Myomectomy Market Share, by End Users, 2016

Figure 7 Global Myomectomy Market Share, by Region, 2016

Figure 8 North America Myomectomy Market Share, by Country, 2016

Figure 9 Europe Myomectomy Market Share, by Country, 2016

Figure 10 Asia Pacific Myomectomy Market Share, by Country, 2016

Figure 11 Middle East & Africa Myomectomy Market Share, by Country, 2016

Figure 12 Global Myomectomy Market: Company Share Analysis, 2016 (%)

Figure 13 Halt Medical, Inc.: Key Financials

Figure 14 Halt Medical, Inc.: Segmental Revenue

Figure 16 Halt Medical, Inc.: Geographical Revenue

Figure 17 Boston Scientific Corporation: Key Financials

Figure 18 Boston Scientific Corporation: Segmental Revenue

Figure 19 Boston Scientific Corporation: Geographical Revenue

Figure 20 CooperSurgical Inc.: Key Financials

Figure 21 CooperSurgical Inc.: Segmental Revenue

Figure 22 CooperSurgical Inc.: Geographical Revenue

Figure 23 F. Hoffmann-La Roche Ltd : Key Financials

Figure 24 F. Hoffmann-La Roche Ltd : Segmental Revenue

Figure 25 F. Hoffmann-La Roche Ltd : Geographical Revenue

Figure 26 Merck & Co., Inc: Key Financials

Figure 27 Merck & Co., Inc: Segmental Revenue

Figure 28 Merck & Co., Inc: Geographical Revenue

Figure 29 C. R. Bard, Inc.: Key Financials

Figure 30 C. R. Bard, Inc.: Segmental Revenue

Figure 31 C. R. Bard, Inc.: Geographical Revenue

Figure 32 Siemens: Key Financials

Figure 33 Siemens: Segmental Revenue

Figure 34 Siemens: Geographical Revenue